Abstract
A female with von Hippel-Lindau (VHL) disease type 2A first presented with erythrocytosis at the age of 9 years. This patient revealed multiple paragangliomas at age 22. After the removal of tumors, a retinal hemangioblastoma developed. Our diagnosis of VHL disease type 2A was confirmed. Moreover, systemic examination showed a duodenal somatostatinoma. Frequent and long-term monitoring is important for patients with pheochromocytomas or paragangliomas, and a screening for VHL disease and other hereditary cancer syndromes is recommended. Recognition of neuroendocrine tumors as a manifestation of VHL disease permits earlier diagnosis and improves prognosis.
Author supplied keywords
Cite
CITATION STYLE
Karasawa, Y., Sakaguchi, M., Minami, S., Kitano, K., Kawa, S., Aoki, Y., … Kiyosawa, K. (2001). Duodenal somatostatinoma and erythrocytosis in a patient with Von Hippel-Lindau disease type 2A. Internal Medicine, 40(1), 38–43. https://doi.org/10.2169/internalmedicine.40.38
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.